CHF6467 active
Phase 1/2Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Neuropathic Foot Ulcers
Conditions
Diabetic Neuropathic Foot Ulcers
Trial Timeline
Oct 17, 2018 → Jan 7, 2021
NCT ID
NCT04077671About CHF6467 active
CHF6467 active is a phase 1/2 stage product being developed by Comac Medical for Diabetic Neuropathic Foot Ulcers. The current trial status is completed. This product is registered under clinical trial identifier NCT04077671. Target conditions include Diabetic Neuropathic Foot Ulcers.
Hype Score Breakdown
Clinical
13
Activity
8
Company
2
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04077671 | Phase 1/2 | Completed |
Competing Products
20 competing products in Diabetic Neuropathic Foot Ulcers